Filter Results :

Your search for Cancer returned 1089 reports

Sort by


Cancer Growth Inhibitors Market & Clinical Pipeline Analysis

08 Apr 2015  |  Published by:  KuicK Research
Pharmaceutical industry consists of various products for cancer treatment and several years of research along with significant investments have helped in developing many innovative products. Every year, new cancer therapeutic belonging to different drug category is introduced across the globe....

$ 2,400.00

Read More

Cancer Targeted Therapy Market & Clinical Insight 2015

08 Apr 2015  |  Published by:  KuicK Research
Cancer targeted therapeutics global market could be broadly divided into small and large molecules segments. Small molecules generate significant shares due to their sheer numbers as compared to large molecules cancer targeted therapeutics. Moreover, they have mature market and they could be c...

$ 3,300.00

Read More

North American Dermatology Treatment Devices Market by Types (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Psoriasis, Hair Removal) - Forecast to 2019

08 Apr 2015  |  Published by:  MicroMarketMonitor
The North American dermatology treatment devices market is estimated to grow at a CAGR of 10.1% from 2014 to 2019. The U.S holds the largest share of the dermatology treatment devices market; however, the Canadian market is expected to grow at the highest CAGR of 11.5% during the forecast period....

$ 2,650.00

Read More

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Colorectal Cancer-API Insights, 2015,report provides Metastatic Colorectal Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe ...

$ 1,250.00

Read More

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015,report provides Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer drugs marketed details and API Manufacturers details across ...

$ 1,250.00

Read More

Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Nonseminomatous Testicular Cancer-API Insights, 2015,report provides Metastatic Nonseminomatous Testicular Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug...

$ 1,250.00

Read More

Nasopharyngeal Cancer-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Nasopharyngeal Cancer-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Nasopharyngeal Cancer. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Nasopharynge...

$ 1,250.00

Read More

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Ovarian Cancer-API Insights, 2015,report provides Metastatic Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Breast Cancer-API Insights, 2015,report provides Metastatic Breast Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF file...

$ 1,250.00

Read More

Medullary Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Medullary Thyroid Cancer-API Insights, 2015,report provides Medullary Thyroid Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF file...

$ 1,250.00

Read More

Medullary Thyroid Cancer-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Medullary Thyroid Cancer-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Medullary Thyroid Cancer. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Medull...

$ 1,250.00

Read More

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). A key objective of DelveInsight...

$ 1,250.00

Read More

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Pancreatic Cancer-API Insights, 2015,report provides Pancreatic Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide...

$ 1,250.00

Read More

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Non Muscle Invasive Bladder Cancer (NMIBC). A key objective of DelveInsight’s report is to establish the understanding for all the pi...

$ 1,250.00

Read More

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Pancreatic Cancer-API Insights, 2015,report provides Metastatic Pancreatic Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe ...

$ 1,250.00

Read More
Total 1089 records.